FDA Inspection 760964 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 1076406

The FDA completed an inspection of Octapharma Plasma, Inc. on December 2, 2011 in North Charleston, SC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 2, 2011
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
North Charleston, SC (United States)

Citations

IDCFRDescription
325821 CFR 640.63(d)Unreliable answers
922521 CFR 606.171Biological product deviation report